Phase 1 Clinical Development Program

This webinar discusses smart processes to include in your Phase 1 clinical development program to save time and cost yet add value to your clinical asset. Cut time, not corners.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

Phase 1 Clinical Development Program

Resources to Consider

From Preclinical Through Phase 1

Phase 1 Study of OMN54 – Aneustat

Strategies and Solutions for Early Phase Formulation Development and...

Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase...

A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

Identification of the Major Circulating Metabolite of Mymd-1 And...

IN Vitro Assessment of the inhibition of Human Organic Anion...

An Unexpected Major Circulating Metabolite M219 Detected in...

A Competitive Ligand-binding Assay for the Detection of Neutralizing...

pTau217 Biomarker Assay

Human C14 AME (hAME) Services